Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan;11(1):6-13.
doi: 10.1097/01.cpm.0000107609.50629.69.

Pulmonary Strongyloidiasis: The Varied Clinical Presentations

Affiliations

Pulmonary Strongyloidiasis: The Varied Clinical Presentations

Babak Mokhlesi et al. Clin Pulm Med. 2004 Jan.

Abstract

Strongyloides stercoralis is a unique parasite. It can complete its life cycle entirely within the human host. As a result, an autoinfection cycle is set up. As long as there is an intact immune system, the host can control the parasitic burden, and the organism may persist for years after the initial inoculum. Most infected individuals experience mild gastrointestinal or pulmonary symptoms that may fluctuate for years. When cell-mediated immunity becomes impaired (ie, corticosteroid use, malignancy, acquired immunodeficiency syndrome), the parasite burden will grow, disseminate, and cause hyperinfection. Strongyloidiasis is endemic in the tropical and subtropical areas of the world; additionally, it is also endemic in the southeastern United States. Strongyloidiasis is associated with asthma, preexisting lung disease, and immunosuppression, including acquired immunodeficiency syndrome. Eosinophilia is not a prerequisite; therefore, the diagnosis of strongyloidiasis requires a high index of suspicion.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Photomicrograph of Strongyloides stercoralis filariform larva recovered from the bronchoalveolar lavage in case 1 (Diff-Quick stain, original magnification ×100)
FIGURE 2
FIGURE 2
Life cycle of Strongyloides stercoralis. See text for more detailed explanation.

Similar articles

Cited by

References

    1. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am. 1993;7:655–682. - PubMed
    1. Grove DI. Human strongyloidiasis. Adv Parasitol. 1996;38:251–309. - PubMed
    1. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755–767. - PubMed
    1. Berk SL, Verghese A, Alvarez S, et al. Clinical and epidemiologic features of strongyloidiasis: a prospective study in rural Tennessee. Arch Intern Med. 1987;147:1257–1261. - PubMed
    1. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis: a case-control study. Arch Intern Med. 1984;144:321–324. - PubMed